INTENSITY THERAPEUTICS, INC.
INTS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001567264
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
17
- +3 vs. Q1 2026
- Total value $4.79M
Superinvestors holding INTS
0
- None of the superinvestors held INTS at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by INTS insiders, newest first.
No open-market purchases or sales by INTS insiders are on file.
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in INTS at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 496,493 | $2.04M | 1.72% | +458,439+1,204.7% | Added |
| KMT WEALTH MANAGEMENT, LLC | 496,493 | $2.04M | 1.72% | +496,493 | New |
| Sentinus, LLC | 26,723 | $109.56K | 0.01% | +3,429+14.7% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 26,569 | $108.93K | 0.00% | +9,728+57.8% | Added |
| SAPIENT CAPITAL LLC | 26,006 | $106.63K | 0.00% | 00.0% | Unchanged |